Patents by Inventor Mary R. Flack

Mary R. Flack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS
    Publication number: 20120276182
    Abstract: The present invention relates to methods for treating and completely curing fungal, yeast, and/or mold infections in human subjects comprising topically administering to a human subject in need thereof an antifungal nanoemulsion composition.
    Type: Application
    Filed: July 9, 2012
    Publication date: November 1, 2012
    Inventors: James R. Baker, JR., Mary R. Flack, Susan M. Ciotti, Joyce A. Sutcliffe
  • METHODS FOR TREATING HERPES VIRUS INFECTIONS
    Publication number: 20120219602
    Abstract: The present invention relates to methods for treating, killing, and/or inhibiting the growth of Herpes viruses in human subjects comprising topically administering to a human subject in need thereof a nanoemulsion composition having antiviral properties.
    Type: Application
    Filed: February 28, 2012
    Publication date: August 30, 2012
    Inventors: Mary R. Flack, Susan Marie Ciotti, Tarek Hamouda, Joyce A. Sutcliffe, James R. Baker, JR.
  • Methods of treating fungal, yeast and mold infections
    Patent number: 8226965
    Abstract: The present invention relates to methods for treating and completely curing fungal, yeast, and/or mold infections in human subjects comprising topically administering to a human subject in need thereof an antifungal nanoemulsion composition.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: July 24, 2012
    Assignee: NanoBio Corporation
    Inventors: James R. Baker, Jr., Mary R. Flack, Susan Marie Ciotti, Joyce A. Sutcliffe
  • METHODS FOR TREATING HERPES VIRUS INFECTIONS
    Publication number: 20100075914
    Abstract: The present invention relates to methods for treating, killing, and/or inhibiting the growth of Herpes viruses in human subjects comprising topically administering to a human subject in need thereof a nanoemulsion composition having antiviral properties.
    Type: Application
    Filed: April 17, 2009
    Publication date: March 25, 2010
    Inventors: Mary R. FLACK, Susan Marie CIOTTI, Tarek HAMOUDA, Joyce A. SUTCLIFFE, James R. Baker, JR.
  • METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS
    Publication number: 20090269380
    Abstract: The present invention relates to methods for treating and completely curing fungal, yeast, and/or mold infections in human subjects comprising topically administering to a human subject in need thereof an antifungal nanoemulsion composition.
    Type: Application
    Filed: April 27, 2009
    Publication date: October 29, 2009
    Inventors: James R. Baker, JR., Mary R. Flack, Susan M. Ciotti, Joyce A. Sutcliffe
  • METHODS AND COMPOSITIONS FOR TREATING ONCHOMYCOSIS
    Publication number: 20090269394
    Abstract: The present invention relates to methods for treating and completely curing fungal, yeast and/or mold infections in human subjects comprising topically administering to a human subject in need thereof an antifungal nanoemulsion composition.
    Type: Application
    Filed: April 27, 2009
    Publication date: October 29, 2009
    Inventors: James R. Baker, JR., Mary R. Flack, Susan Ciotti, Joyce A. Sutcliffe
  • Gossypol for the treatment of cancer
    Patent number: 6114397
    Abstract: A method for treating cancer in a human, which comprises administering to the human subject an anti-cancer effective amount of a compound selected from gossypol, gossypol acetic acid, gossypolone, metabolites thereof, or physiologically acceptable salts thereof. Also included is a method for treating cancer in a human which comprises administering to the human subject an anti-cancer effective amount of any of the compounds listed above in combination with an anti-cancer effective amount of other conventional chemotherapeutic agents. Finally, the invention also encompasses a pharmaceutical composition comprising an anti-cancer effective amount of gossypol, gossypol acetic acid, or gossypolone, and an anti-cancer effective amount of a conventional chemotherapeutic agent, or combinations of the latter.
    Type: Grant
    Filed: January 27, 1995
    Date of Patent: September 5, 2000
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Mary R. Flack, Richard Knazek, Marcus Reidenberg
  • Gossypol acetic acid for the treatment of cancer
    Patent number: 5385936
    Abstract: A method for treating cancer in a human, which comprises administering to the human subject an anti-cancer effective amount gossypol acetic acid. Also included is a method for treating cancer in a human which comprises administering to the human subject an anti-cancer effective amount of gossypol acetic acid in combination with an anti-cancer effective amount of other conventional chemotherapeutic agents. Finally, the invention also encompasses a pharmaceutical composition comprising an anti-cancer effective amount of gossypol acetic acid, and an anti-cancer effective amount of a conventional chemotherapeutic agent, or combinations of the latter.
    Type: Grant
    Filed: July 12, 1990
    Date of Patent: January 31, 1995
    Assignee: The United States of America as represented by the Secretary of the Department of the Health and Human Services
    Inventors: Mary R. Flack, Richard Knazek, Marcus Reidenberg
  • Gossypolone for the treatment of cancer
    Patent number: RE40862
    Abstract: A method for treating cancer in a human, which comprises administering to the human subject an anti-cancer effective amount of a compound selected from gossypol, gossypol acetic acid, gossypolone, metabolites thereof, or physiologically acceptable salts thereof. Also included is a method for treating cancer in a human which comprises administering to the human subject an anti-cancer effective amount of any of the compounds listed above in combination with an anti-cancer effective amount of other conventional chemotherapeutic agents. Finally, the invention also encompasses a pharmaceutical composition comprising an anti-cancer effective amount of gossypol, gossypol acetic acid, or gossypolone, and an anti-cancer effective amount of a conventional chemotherapeutic agent, or combinations of the latter.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: July 21, 2009
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Mary R. Flack, Richard Knazek, Marcus Reidenberg